| Autor: |
Kaushik P. Venkatesh, Marium M. Raza, James A. Diao, Joseph C. Kvedar |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
npj Digital Medicine, Vol 5, Iss 1, Pp 1-3 (2022) |
| Druh dokumentu: |
article |
| ISSN: |
2398-6352 |
| DOI: |
10.1038/s41746-022-00662-1 |
| Popis: |
Abstract With the increasing number of FDA-approved artificial intelligence (AI) systems, the financing of these technologies has become a primary gatekeeper to mass clinical adoption. Reimbursement models adapted for current payment schemes, including per-use rates, are feasible for early AI products. Alternative and complementary models may offer future payment options for value-based AI. A successful reimbursement strategy will align interests across stakeholders to guide value-based and cost-effective improvements to care. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
Full text from SpringerLink